YK Bioventures Opportunities GP I, LLC's Form 4 filing
Cero Therapeutics Holdings, Inc. (CERO) · filed Dec 13, 2024
- Accession no.
- 0001415889-24-029371
- Filed
- Dec 13, 2024, 6:41 PM ET
- Trade date
- Dec 11-13, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $400.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| YK Bioventures Opportunities GP I, LLCCIK 0002042634 | 10% Owner |
| YK Bioventures Opportunities Fund I, L.P.CIK 0002042636 | 10% Owner |
| Kossar Mitchell WilliamCIK 0002042691 | 10% Owner |
| Yeung Gary KahingCIK 0002042700 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 11, 2024 | Common Stock | SSaleDisposed | −1,343,801 | $0.08 | −$107,504.08 | 17,618,618 | Indirect | |
| Dec 12, 2024 | Common Stock | SSaleDisposed | −1,614,541 | $0.07 | −$113,017.87 | 16,004,077 | Indirect | |
| Dec 13, 2024 | Common Stock | SSaleDisposed | −2,998,908 | $0.06 | −$179,934.48 | 13,005,169 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.